Results 31 to 40 of about 3,377,180 (268)

Effects of passage through the digestive tract on incretin secretion: Before and after birth

open access: yesJournal of Diabetes Investigation, 2021
Aims/Introduction It was reported that fetuses secrete endogenous incretin; however, the stimulants of fetal incretin secretion are not fully understood.
Seiichi Tomotaki   +10 more
doaj   +1 more source

Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor

open access: yeseLife, 2021
Glucose-dependent insulinotropic polypeptide (GIP) is a peptide hormone that exerts crucial metabolic functions by binding and activating its cognate receptor, GIPR.
Fenghui Zhao   +17 more
doaj   +1 more source

Glucose-Dependent Insulinotropic Polypeptide Plasma Level Influences the Effect of n-3 PUFA Supplementation

open access: yesDiagnostics, 2022
Elevated glucose-dependent insulinotropic peptide (GIP) levels in obesity may predict the metabolic benefits of n-3 PUFA supplementation. This placebo-controlled trial aimed to analyze fasting and postprandial GIP response to 3-month n-3 PUFA ...
Joanna Goralska   +9 more
doaj   +1 more source

Role of Melatonin, Galanin, and RFamide Neuropeptides QRFP26 and QRFP43 in the Neuroendocrine Control of Pancreatic β-Cell Function

open access: yesFrontiers in Endocrinology, 2017
Glucose homeostasis is finely regulated by a number of hormones and peptides released mainly from the brain, gastrointestinal tract, and muscle, regulating pancreatic secretion through cellular receptors and their signal transduction cascades.
Iacopo Gesmundo   +4 more
doaj   +1 more source

Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity

open access: yesMolecular Metabolism, 2023
Objective: Glucagon/glucagon-like peptide-1 (GLP-1) receptor co-agonists may provide greater weight loss than agonists targeting the GLP-1 receptor alone.
Martin Haljeta Friedrichsen   +6 more
doaj   +1 more source

β-Catenin mediates glucose-dependent insulinotropic polypeptide increases in lysyl oxidase expression in osteoblasts

open access: yesBone Reports, 2021
Osteoblast lysyl oxidase (LOX) is a strongly up-regulated mRNA and protein by the glucose-dependent insulinotropic polypeptide (GIP). LOX is critically required for collagen maturation, and was shown to be dramatically down-regulated in a mouse model of ...
Eileen J. Daley, Philip C. Trackman
doaj   +1 more source

HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide [PDF]

open access: yesScientific Reports, 2019
AbstractMutations in the HNF4A gene cause MODY1 and are associated with an increased risk of Type 2 diabetes mellitus. On the other hand, incretins are hormones that potentiate reductions in blood glucose levels. Given the established role of incretin-based therapy to treat diabetes and metabolic disorders, we investigated a possible regulatory link ...
Girard, Romain   +8 more
openaire   +2 more sources

Glucose-dependent insulinotropic polypeptide - a new link in the development of obesity

open access: yesОжирение и метаболизм, 2015
Objective. Glucose-dependent insulinotropic polypeptide (GIP) as well as glucagon-like peptide-1 (GLP-1) is intestinal incretin hormone that stimulates insulin secretion in response to feeding. Much evidence of GIP contribution to obesity development has
Ekaterina Alekseevna Shestakova   +3 more
doaj   +1 more source

Establishment of an enzyme-linked immunosorbent assay for mouse pancreatic polypeptide clarifies the regulatory mechanism of its secretion from pancreatic γ cells.

open access: yesPLoS ONE, 2022
Pancreatic polypeptide (PP), secreted from γ cells of the islets of Langerhans, is a 36 amino-acid peptide encoded by the Ppy gene. Although previous studies have reported that PP causes a decrease in appetite, the molecular mechanism that regulates PP ...
Daisuke Saito   +7 more
doaj   +1 more source

Development and validation of novel fluorescent probes to advance research into glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP1) receptor localisation and activity [PDF]

open access: yes
Diabetes and obesity are chronic conditions which cause significant impact upon the individual, healthcare services and society. Medications agonising glucagon-like peptide-1 receptor (GLP1R) and dual agonists targeting GLP1R and glucose-dependent ...
De Bray, Anne Yingchol
core   +1 more source

Home - About - Disclaimer - Privacy